Treatment of melasma with oral administration of compound tranexamic acid: A preliminary clinical trial

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 3, 2014, Pages 393-394

  Li, Y ^a   Sun, Q ^a   He, Z ^a   Fu, L ^a   He, C ^a   Yan, Y ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADMINISTRATION, ORAL; ADULT; FEMALE; HUMANS; MALE; MELANOSIS; MIDDLE AGED; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84894411400     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12209     Document Type: Letter

References (4)

1. Situm M, Kolic̈ M, Bolanca Z, Ljubicic̈ I, Misanovic̈ B,. Melasma-updated treatments. Coll Antropol 2011; 35 (Suppl 2): 315-318.
2. Piamphogsant T,. Treatment of melasma: a review with personal experience. Int J Dermatol 1998; 37: 897-903.
3. Maeda K, Naganuma M,. Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation induced pigmentation. J Photochem Photobiol B 1998; 47: 130-141.
4. Konishi Natsuko, Kawada Akira, Morimoto Yoshinobu, Watake Asami, Matsuda Hiromasa, Oiso Naoki,. Shigeru kawaranew approach to the evaluation of skin color of pigmentary lesions using skin tone color scale. J Invest Dermatol 2007; 34: 441-446.